Results 131 to 140 of about 49,586 (211)

Improving Data Quality: Consistency and Accuracy [PDF]

, 2007
Cong, Gao, Fan, Wenfei, Geerts, Floris, Jia, Xibei, Ma, Shuai   +4 more
core  

Tafamidis: a new treatment for ATTR cardiomyopathy [PDF]

Nature Reviews Cardiology, 2018
openaire   +2 more sources

Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study. [PDF]

Circulation
Razvi Y, Rauf MU, Porcari A, Mansell J, Sheikh A, Ioannou A, Whelan CJ, Venneri L, Martinez-Naharro A, Hutt DF, Rowczenio D, Gilbertson JA, Wechalekar AD, Lachmann HJ, Hawkins PN, Fontana M, Gillmore JD.   +16 more
europepmc   +1 more source

Low burden transthyretin cardiac amyloidosis on cardiac magnetic resonance: comprehensive phenotyping and distinction from hypertrophic phenocopies. [PDF]

Eur Heart J Imaging Methods Pract
Mengesha B, Prabhakar S, Small GR, Chih S, Thornhill R, Paterson DI.   +5 more
europepmc   +1 more source

Transthyretin Cardiac Amyloidosis and Heart Failure: State-of-the-Art Review and Practice Guidance. [PDF]

Rev Cardiovasc Med
Bukhari S, Hamza M, Malik A.
europepmc   +1 more source

Initial Capture Failure With Delayed Resolution in Atrial Leadless Pacemaker Implantation: A Case of ATTR Amyloidosis With Sinus Node Dysfunction. [PDF]

J Arrhythm
Takada Y, Kamoshida J, Terasawa M, Satomi K, Yazaki Y.   +4 more
europepmc   +1 more source

Transthyretin Cardiac Amyloidosis With Reduced Ejection Fraction in a 47-Year-Old Man: An Unusual Presentation. [PDF]

Cureus
Moujahid M, Allalat I, Lamtai M, Fellat N.   +3 more
europepmc   +1 more source

Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. [PDF]

Future Cardiol
Sarswat N, Ambardekar AV, Alexander KM, Cuddy SA, Stern L, Poulsen SH, Tschöpe C, Sekijima Y, Sheikh FH, Griffin JM, Judge DP, Gillmore J, Masri A.   +12 more
europepmc   +1 more source